Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Diaz JMT"'
Autor:
Mekinian A; Service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, AP-HP, Hôpital Saint Antoine, F-75012, Paris, France. arsene.mekinian@aphp.fr., Zhao LP; Service d'hématologie, Université de Paris Cité, AP-HP, Hôpital Saint Louis, F-75010, Paris, France., Chevret S; APHP, Department of Biostatistics and Medical Information, APHP, Saint-Louis Hospital, Paris, INSERM, UMR-1153, ECSTRA Team, Paris, France., Desseaux K; APHP, Department of Biostatistics and Medical Information, APHP, Saint-Louis Hospital, Paris, INSERM, UMR-1153, ECSTRA Team, Paris, France., Pascal L; Service d'hématologie, Hôpital Saint Vincent de Paul, Lille, France., Comont T; Service d'hématologie, CHU Toulouse, Toulouse, France., Maria A; Service de médecine interne CHU Montpellier, Montpellier, France., Peterlin P; Service d'hématologie, CHU Nantes, Nantes, France., Terriou L; Service d'hématologie, CHU Lille, Lille, France., D'Aveni Piney M; Service d'hématologie, CHU Nancy, Nancy, France., Gourin MP; Service d'hématologie, CHU Limoges, Limoges, France., Vey N; Service d'hématologie, CHU Marseille, Marseille, France., Rauzy OB; Service d'hématologie, CHU Toulouse, Toulouse, France., Grobost V; Internal Medicine Department, Clermont-Ferrand University Hospital, 1 Rue Lucie et Raymond Aubrac, 63003, Clermont Ferrand, France., Bezanahary H; Service de médecine interne CHU Dupuytren 2, 87000, Limoges, France., Dimicoli-Salazar S; Service d'hématologie, CHU Bordeaux, Bordeaux, France., Banos A; Service d'hématologie, Centre Hospitalier de Biarritz, Biarritz, France., Wickenhauser S; Service d'hématologie, CHU Nimes, Nimes, France., De Renzis B; Service d'hématologie, CHU Clermont Ferrand, Clermont Ferrand, France., Durot E; Service d'hématologie, CHU Reims, Reims, France., Natarajan-Amé S; Service d'hématologie, Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France., Voillat L; Service d'hématologie, CHU Limoges, Limoges, France., Chermat F; Service d'hématologie, Université de Paris Cité, AP-HP, Hôpital Saint Louis, F-75010, Paris, France., Lemaire K; Service d'hématologie, Université de Paris Cité, AP-HP, Hôpital Saint Louis, F-75010, Paris, France., Jachiet V; Service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, AP-HP, Hôpital Saint Antoine, F-75012, Paris, France., Himberlin C; Service d'hématologie, CHU Reims, Reims, France., Thépot S; Service d'hématologie, CHU d'Angers, Angers, France., Diaz JMT; Service d'hématologie, CHU de Poitiers, Poitiers, France., Frenzel L; AP-HP, Hôpital Necker, Paris, France., Gyan E; Service d'hématologie, CHRU de Tours - Bretonneau, Tours, France., Denis G; Service d'hématologie, CH de Rochefort, Rochefort, France., Hirsch P; Service d'hématologie biologique, Sorbonne Université, INSERM UMR938, Centre de Recherche Saint-Antoine (CRSA), AP-HP, Hôpital Saint Antoine, Paris, France., Kosmider O; Service d'hématologie biologique, APHP, Hôpital Cochin, Paris, France., Ades L; Service d'hématologie, Université de Paris Cité, AP-HP, Hôpital Saint Louis, F-75010, Paris, France., Fain O; Service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, AP-HP, Hôpital Saint Antoine, F-75012, Paris, France., Fenaux P; Service d'hématologie, Université de Paris Cité, AP-HP, Hôpital Saint Louis, F-75010, Paris, France.
Publikováno v:
Leukemia [Leukemia] 2022 Nov; Vol. 36 (11), pp. 2739-2742. Date of Electronic Publication: 2022 Sep 14.
Autor:
Kubasch AS; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany.; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany., Giagounidis A; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Department of Oncology, Hematology and Palliative Care, Marien Hospital, Düsseldorf, Germany., Metzgeroth G; Department of Hematology and Oncology, University Medical Centre, Mannheim, Germany., Jonasova A; 1st Medical Department - Hematology, General Hospital, Prague, Czech Republic., Herbst R; Medizinische Klinik III, Klinikum Chemnitz, Chemnitz, Germany., Diaz JMT; Department of Hematology and Oncology, CHU de Poitiers, Poitiers, France., De Renzis B; Service d'Hématologie Clinique Adulte, Clermont Ferrand, France., Götze KS; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Department of Medicine III, Technical University of Munich, Munich, Germany., Huetter-Kroenke ML; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Gourin MP; CHU Limoges, Limoges, France., Slama B; Service d'Hématologie, Centre Hospitalier d'Avignon, Avignon, France., Dimicoli-Salazar S; University Hospital Bordeaux, Pessac, France., Cony-Makhoul P; Centre Hospitalier Annecy-Genevois, Pringy, France., Laribi K; Centre Hospitalier Du Mans, Le Mans, France., Park S; Department of Hematology, CHU Grenoble, Grenoble, France., Jersemann K; GWT-TUD GmbH, Dresden, Germany., Schipp D; DS-Statistics, Rosenthal-Bielatal, Germany., Metzeler KH; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany.; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany., Tiebel O; Institute of Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technical University Dresden, Dresden, Germany., Sockel K; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Gloaguen S; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany.; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; GWT-TUD GmbH, Dresden, Germany., Mies A; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Chermat F; Groupe Francophone des Myélodysplasies, Paris, France., Thiede C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Sapena R; Groupe Francophone des Myélodysplasies, Paris, France., Schlenk RF; Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.; NCT-clinical Trials Office, German Cancer Research Center, Heidelberg, Germany., Fenaux P; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Groupe Francophone des Myélodysplasies, Paris, France.; Hématologie Clinique, Hôpital Saint-Louis, Paris, France., Platzbecker U; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany. uwe.platzbecker@medizin.uni-leipzig.de.; German MDS Study Group (D-MDS), Leipzig, Germany. uwe.platzbecker@medizin.uni-leipzig.de.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany. uwe.platzbecker@medizin.uni-leipzig.de., Adès L; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Groupe Francophone des Myélodysplasies, Paris, France.; Hématologie Clinique, Hôpital Saint-Louis, Paris, France.
Publikováno v:
Leukemia [Leukemia] 2022 Oct; Vol. 36 (10), pp. 2519-2527. Date of Electronic Publication: 2022 Sep 07.
Autor:
Gallego Hernanz MP; CHU de Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.; INSERM, CIC-P 1402, Poitiers, France., Sorel N; CHU de Poitiers, Service de Cancérologie Biologique, Poitiers, France., Bouyer S; CHU de Poitiers, Service d'Hématologie Biologique, Poitiers, France., Desmier D; CHU de Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.; INSERM, CIC-P 1402, Poitiers, France., Chollet M; CHU de Poitiers, Service d'Hématologie Biologique, Poitiers, France., Maillard N; CHU de Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.; INSERM, CIC-P 1402, Poitiers, France., Brizard F; CHU de Poitiers, Service d'Hématologie Biologique, Poitiers, France., Moya N; CHU de Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.; INSERM, CIC-P 1402, Poitiers, France., Diaz JMT; CHU de Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.; INSERM, CIC-P 1402, Poitiers, France., Leleu X; CHU de Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.; INSERM, CIC-P 1402, Poitiers, France., Chomel JC; CHU de Poitiers, Service de Cancérologie Biologique, Poitiers, France.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Jul; Vol. 61 (7), pp. 1709-1713. Date of Electronic Publication: 2020 Feb 20.
Autor:
Augeul-Meunier K; Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France., Chretien ML; Centre Hospitalo-Universitaire Dijon, Dijon, France., Stoppa AM; Institut Paoli Calmette, Marseille, France., Karlin L; Centre Hospitalier Lyon Sud, Lyon, France., Benboubker L; Centre Hospitalo-Universitaire Bretonneau, Tours, France., Diaz JMT; Centre Hospitalo-Universitaire La Miletrie, Poitiers, France., Mohty M; Hôpital Saint-Antoine, Paris, France., Yakoub-Agha I; CHU de Lille, LIRIC INSERM U995, Université Lille 2, Lille, France., Bay JO; Centre Hospitalo-Universitaire Estaing, Clermont-Ferrand, France., Perrot A; Centre Hospitalo-Universitaire Vandoeuvre-les-Nancy, Nancy, France., Bulabois CE; Centre Hospitalo-Universitaire Grenoble, Grenoble, France., Huynh A; Institut Universitaire du Cancer, Toulouse, France., Mercier M; Centre Hospitalo-Universitaire Angers, Angers, France., Frenzel L; Hôpital Necker, Paris, France., Avet-Loiseau H; Institut Universitaire du Cancer, Toulouse, France., de Latour RP; Hôpital Saint-Louis, Paris, France., Cornillon J; Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France. jerome.cornillon@icloire.fr.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2018 Jun; Vol. 53 (6), pp. 749-755. Date of Electronic Publication: 2018 Mar 09.